Hüttner, Felix J

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac – the phase II randomized controlled PROSPER trial

Hüttner, F. J., Klotz, R., Giese, N. A., Kong, B., Ahmed, A., Merz, D., Pöchmann, A., Burghaus, I., Hackert, T., Strobel, O., et al. (2025) · Langenbeck's Archives of Surgery

Cancer, Stress, Anesthesia, and Immune ResponsePancreatic and Hepatic Oncology Research

Cited by 15

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial

Hüttner, F. J., Rooman, I., Bouche, G., Knebel, P., Hüsing, J., Mihaljevic, A. L., Hackert, T., Strobel, O., Büchler, M. W., & Diener, M. K. (2020) · BMJ Open

Cancer, Stress, Anesthesia, and Immune ResponsePancreatic and Hepatic Oncology Research

Cited by 13

Impact of perioperative steroid administration in patients undergoing elective liver resection: Meta-analysis

Jötten, L., Steinkraus, K. C., Traub, B., Graf, S., Mihaljevic, A. L., Kornmann, M., Michalski, C. W., & Hüttner, F. J. (2022) · BJS Open

Cancer, Stress, Anesthesia, and Immune ResponseEnhanced Recovery After Surgery

Cited by 10

Influence of beta-blockers and other non-cancer drugs on outcomes after pancreatic cancer resection

Hüttner, F. J., Mauch, M., Heckler, M., Hackert, T., Büchler, M. W., Probst, P., & Diener, M. K. (2023) · British Journal of Surgery

Pancreatic and Hepatic Oncology ResearchCancer, Stress, Anesthesia, and Immune Response

Cited by 7